Pro Pharmaceuticals Group Enhances Global Sourcing and Clinical Supply Capabilities

Pro Pharmaceuticals Group continues to strengthen its position as a trusted partner in global pharmaceutical supply, with a growing portfolio of structured export agreements supporting clinical research and healthcare delivery in Europe and beyond.

Our ability to source registered pharmaceutical products from major global markets — including Europe and the United States — enables us to meet complex clinical and regulatory requirements for comparator and specialty medicines.

These recent agreements further demonstrate our core capabilities in:

• Global product sourcing from licensed suppliers

• Navigating EU and international regulatory frameworks

• Coordinating temperature-controlled and time-sensitive deliveries

• Executing multi-shipment logistics under DAP Incoterms (2020)

• Supporting compliance for clinical trials and research programs

As we expand our role in supplying medicines to support international clinical platforms, Pro Pharmaceuticals Group remains committed to operational excellence, reliability, and patient-focused service.

This growth reflects our ongoing mission to Accelerate Access and Transform Lives Worldwide — ensuring critical medicines reach the right stakeholders, at the right time, anywhere in the world.